|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| A61K 47/38 | (2006.01) |
| (11) | Number of the document | 1660037 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04779411.0 |
| Date of filing the European patent application | 2004-07-29 | |
| (97) | Date of publication of the European application | 2006-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2011-08-31 |
| (46) | Date of publication of the claims translation | 2011-12-27 |
| (86) | Number | PCT/US2004/024345 |
| Date | 2004-07-29 |
| (87) | Number | WO 2005/016262 |
| Date | 2005-02-24 |
| (30) | Number | Date | Country code |
| 635221 | 2003-08-06 | US |
| (72) |
BROWN, Josiah, US
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-Ku, Tokyo 108-8242,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Aripiprazolo injekcinė suspensija |
| Aripiprazole injectable suspension |
| Payment date | Validity (years) | Amount | |
| 2023-07-14 | 347.00 EUR |